AllianceBernstein
ABCL icon

AllianceBernstein’s AbCellera Biologics ABCL Stock Holding History

AllianceBernstein’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,472
Closed -$225K – 3140
2023
Q4 		$225K Buy
+39,472
New +$183K ﹤0.01% 2943
2023
Q2 		– Sell
-233,100
Closed -$1.76M – 3164
2023
Q1 		$1.76M Hold
233,100
– – ﹤0.01% 1938
2022
Q4 		$2.36M Hold
233,100
– – ﹤0.01% 1819
2022
Q3 		$2.31M Hold
233,100
– – ﹤0.01% 1798
2022
Q2 		$2.48M Buy
+233,100
New +$1.97M ﹤0.01% 1812
2022
Q1 		– Sell
-125,000
Closed -$1.79M – 3262
2021
Q4 		$1.79M Buy
+125,000
New +$1.9M ﹤0.01% 2206

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return